EGF and glioblastoma: Moreover, besides EGF, EGFRvIII has also been observed to be one of the most prolific EGFR variants in GBM and seems to have a 267-amino-acid deletion throughout the extracellular domain, culminating in a receptor that’s unable to bind ligands yet remains catalytically active.